ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases
February 21, 2019Calypso Biotech, an emerging leader in the development of therapeutic antibodies for autoimmune diseases, announces today the closing of a €20M Series A financing co-led by Gilde Healthcare and Inkef Capital..... -
Catalyst's long-delayed Firdapse snags FDA nod, but pricing questions loom
December 05, 2018It took a breakthrough designation, orphan drug status, an embarrassing up-front rejection letter and some extra trials, but Catalyst Pharmaceuticals has finally crossed the finish line with Firdapse. -
Which of the Blockbuster Drugs on the Autoimmune Drug Market Will Show the Glory that Humira Had?(3)
June 08, 2018Among other autoimmune diseases, anti-IL-12/23 Stelara does not have advantages over TNFα inhibitors... -
BMS's Orencia receives FDA approval for treatment of active psoriatic arthritis in adults
July 13, 2017Orencia now approved in three autoimmune diseases. -
Regen BioPharma sees success in Its pre-clinical small molecule optimization program for NR2F6
April 14, 2017The company's small molecule drug program is aimed at treating cancer and autoimmune diseases.
Pharma Sources Insight January 2025
